In the course of inspections, Vikram Punia, the President of the Pharmasyntez Group of Companies, the representatives of the Tyumen Region Administration and V.A. Vorobeichik, the CEO of LLC DSM, did not detect any irregularities. The works are proceeding in accordance with the construction deadlines and it is planned to implement this project by the end of 2019.
The project provides for the construction of the production facility, storage buildings, and laboratory facilities with a total area of over 20 000 square meters. The future plant will become one of the largest hormonal drug manufacturing plants in Europe.
At the moment, the works on the assembly of the metal frames, installation of the sandwich panels and reinforcement cage tying for floor pouring are being carried out.